Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04941703 · ClinicalTrials.gov registry record · Phase 1
"CHANGE COVID-19 Severity"
A Phase 1 study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT04941703 is a Phase 1 study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT04941703, a Phase 1 study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
We are conducting an investigator-initiated, single center, blinded, placebo-controlled, randomized clinical trial evaluating magnesium citrate combined with a probiotic for the treatment of adults hospitalized with COVID-19.
Interventions
- DRUG Magnesium Citrate plus probiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-11-04 |
| Est. Completion | 2022-06-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04941703
The ClinicalTrials.gov registry entry for NCT04941703 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnesium Citrate plus probiotic is the first listed.
NCT04941703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04941703 about?
NCT04941703 is a clinical study titled ""CHANGE COVID-19 Severity"". We are conducting an investigator-initiated, single center, blinded, placebo-controlled, randomized clinical trial evaluating magnesium citrate combined with a probiotic for the treatment of adults hospitalized with COVID-19.
What is the current status of trial NCT04941703?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2021-11-04. Estimated completion is 2022-06-25.
What interventions are being tested in trial NCT04941703?
The interventions under investigation include: Magnesium Citrate plus probiotic (DRUG).
Who is sponsoring clinical trial NCT04941703?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.